We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Alan Myers PharmD, PhD, RPh

Alan L. Myers PharmD, PhD, RPh

Associate Professor of Pharmacology, Department of Diagnostic & Biomedical Sciences, School of Dentistry, The University of Texas Health Science Center at Houston, Houston, Texas

Dr. Myers is an Associate Professor of Pharmacology in the Department of Diagnostic and Biomedical Sciences at The University of Texas Health Science Center, School of Dentistry at Houston (UTHealth Houston School of Dentistry). He received his Doctorate in Pharmacy (PharmD) from the University of the Sciences in Philadelphia, and PhD in Pharmacology from West Virginia University. Dr. Myers completed Fellowship training in Pharmacokinetics and Pharmacodynamics at the University of Maryland, School of Pharmacy.

During his career, Dr. Myers has practiced Community Pharmacist and Oncology Pharmacist at The University of Texas, M.D. Anderson Cancer Center. He has taught various chemistry and pharmacology-based courses at Drake University College of Pharmacy & Health Sciences and at his current position at UTHealth Houston School of Dentistry. Dr. Myers has held several consulting positions, including with Migenesys Inc. as a pharmacogenetics expert.

Dr. Myers’ research interests span the fields of basic and clinical pharmacological sciences. This includes pharmacokinetic modeling in investigative cancer trials, drug bioanalysis pairing chromatography and mass spectroscopy, chemical stability of drugs, and toxicokinetics of FDA-approved medications and natural substances, including areca (betel) nut alkaloids. He has published over 35 peer-reviewed articles and has been the recipient of multiple internal and external grant awards to fund his research.

He is an active member of the American Dental Education Association (ADEA), International Association for Dental Research (IADR), and American Association for Dental, Oral, and Craniofacial Research (AADOCR), among other professional organizations.


No disclosures reported.